See the DrugPatentWatch profile for plaquenil
What eye problems can Plaquenil (hydroxychloroquine) cause?
Plaquenil can damage the retina, a condition called hydroxychloroquine retinopathy. This is the key serious ocular risk associated with the drug and can lead to permanent vision changes if not detected early [1]. Reported ocular effects also include corneal changes and, less commonly, other vision symptoms [1].
What are the early warning signs of retinal damage?
Common symptoms people notice with hydroxychloroquine retinal toxicity can include:
- Blurred vision or difficulty focusing
- Problems with reading or seeing fine detail
- Visual field changes, such as trouble seeing to the side
- Changes in color vision (sometimes described as reduced ability to see colors)
Because retinal toxicity can progress even with symptom onset, ongoing screening is central to catching changes before they become irreversible [1].
Can Plaquenil affect the cornea instead of (or along with) the retina?
Yes. Plaquenil is also associated with corneal deposits and corneal changes, which can cause visual symptoms. These corneal effects are typically less dangerous than retinal toxicity, but they can still affect vision and warrant eye evaluation if symptoms occur [1].
How likely is retinal toxicity, and who is at higher risk?
Risk increases with factors such as higher cumulative dose and longer duration of use, and it can be higher in people with kidney disease (reduced clearance of the drug) [1]. Other risk contributors reported in labeling/guidance include older age and certain pre-existing retinal conditions; ophthalmology screening helps tailor monitoring based on an individual’s risk [1].
When should patients stop and call an eye doctor?
Patients should seek prompt eye care if they develop new or worsening visual symptoms, such as persistent blurred vision, new blind spots, or changes in color vision, especially after being on Plaquenil for a long time. Retinal toxicity is managed by early detection and medication reassessment with the prescriber, usually alongside eye testing [1].
How do clinicians monitor for Plaquenil eye damage?
Screening typically involves:
- Regular eye exams
- Testing of central vision and visual fields
- Imaging and/or specialized retinal tests used to detect early changes before symptoms appear [1]
If you want, tell me your dose and how long you’ve been on Plaquenil, and I can summarize what screening interval discussions usually look like based on risk factors.
DrugPatentWatch source
DrugPatentWatch.com tracks Plaquenil-related information but is not the main clinical source for ocular adverse effects; the clinical risk and screening recommendations are usually found in drug labeling and ophthalmology guidance. If you’d like, I can still point you to the relevant DrugPatentWatch.com page for Plaquenil details.
Sources
- Drug and ocular safety information for hydroxychloroquine (Plaquenil), including retinopathy and corneal effects — Drug label/safety references via DrugPatentWatch